CompletedPhase 3NCT00495651

Early Antiretroviral Treatment and/or Early Isoniazid Prophylaxis Against Tuberculosis in HIV-infected Adults (ANRS 12136 TEMPRANO)

Studying Primary genito-urinary tuberculosis

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: French National Agency for Research on AIDS and Viral Hepatitis
Principal Investigator: Xavier Anglaret, MD, PhD
Université Bordeaux 2
Intervention: Antiretroviral medications(drug)
Enrollment: 2073 target
Eligibility: 18 years · All sexes
Timeline: 2008 – 2015

Study locations (9)

Centre de prise en charge de personnes vivant avec le VIH la pierre angulaire, Abidjan, Côte d’Ivoire
Centre de Prise en Charge et de Formation ACONDA, Abidjan, Côte d’Ivoire
Centre de Suivi des donneurs de sang, Centre National de Transfusion Sanguine, Abidjan, Côte d’Ivoire
Centre Intégré de Recherches Biocliniques d'Abidjan, Abidjan, Côte d’Ivoire
Centre médico-social El Rapha, Abidjan, Côte d’Ivoire
Formation Sanitaire Urbaine Anonkoua Kouté, Abidjan, Côte d’Ivoire
Hopital Général Felix Houphouet Boigny, Abidjan, Côte d’Ivoire
Service des Maladies Infectieuses et Tropicales, CHU de Treichville, Abidjan, Côte d’Ivoire
Unité de Soins Ambulatoires et de Conseil, CHU de Treichville, Abidjan, Côte d’Ivoire

Collaborators

Gilead Sciences · Merck Sharp & Dohme LLC

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00495651 on ClinicalTrials.gov

Other trials for Primary genito-urinary tuberculosis

Additional recruiting or active studies for the same condition.

See all trials for Primary genito-urinary tuberculosis →

← Back to all trials